TNF and COVID-19: Many studies have demonstrated that an excessive inflammatory response may be a key contributor to an adverse outcome of COVID-19 (Heidari Nia et al., 2022; Zheng et al., 2022; Falck-Jones et al., 2023; Li et al., 2023) and that tumor necrosis factors (TNFs) play a vital role in initiating the inflammatory cascade response.